|
Originally published In Press as doi:10.1074/jbc.M503162200 on May 5, 2005
J. Biol. Chem., Vol. 280, Issue 27, 25621-25628, July 8, 2005
Membrane Cholesterol Content Accounts for Developmental Differences in Surface B Cell Receptor Compartmentalization and Signaling*
Fredrick G. Karnell ,
Randall J. Brezski ,
Leslie B. King,
Michael A. Silverman, and
John G. Monroe
From the
Department of Pathology and Laboratory Medicine, University of
Pennsylvania, Philadelphia, Pennsylvania 19104-6160
Recent studies argue for an important role for cholesterol in maintaining
plasma membrane heterogeneity and influencing a variety of cellular processes,
including signaling, adhesion, and permeability. Here, we document that
tolerance-sensitive transitional immature B cells maintain significantly lower
membrane unesterified cholesterol levels than mature-stage splenic B cells. In
addition, the relatively low level of cholesterol in transitional immature B
cells impairs compartmentalization of their B cell receptor (BCR) into
cholesterol-enriched domains following BCR aggregation and reduces their
ability to sustain certain aspects of BCR signaling as compared with mature B
cells. These studies establish an unexpected difference in the lipid
composition of peripheral transitional immature and mature B cells and point
to a determining role for development-associated differences in cholesterol
content for the differential responses of these B cells to BCR engagement.
Received for publication, March 22, 2005
, and in revised form, April 26, 2005.
* This work was supported by Training Grant AI055428 (to F. G. K.) and Grants
AI43620 and AI32592 from the National Institutes of Health (to J. G. M. and R.
J. B.). The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section 1734
solely to indicate this fact.
Both authors contributed equally to this work.
To whom correspondence should be addressed: University of Pennsylvania, 421
Curie Blvd., BRB2/3, Rm. 311, Philadelphia, PA 19104. Tel.: 215-898-2873; Fax:
215-573-2014; E-mail:
monroej{at}mail.med.upenn.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. J. Gross, J. R. Lyandres, A. K. Panigrahi, E. T. L. Prak, and A. L. DeFranco
Developmental Acquisition of the Lyn-CD22-SHP-1 Inhibitory Pathway Promotes B Cell Tolerance
J. Immunol.,
May 1, 2009;
182(9):
5382 - 5392.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Johnson, M. Boyle, A. Bashashati, S. Leach, A. Brooks-Wilson, L. H. Sehn, M. Chhanabhai, R. R. Brinkman, J. M. Connors, A. P. Weng, et al.
Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival
Blood,
April 16, 2009;
113(16):
3773 - 3780.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Deans and M. J. Polyak
FMC7 is an epitope of CD20
Blood,
February 15, 2008;
111(4):
2492 - 2492.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Brezski and J. G. Monroe
B Cell Antigen Receptor-Induced Rac1 Activation and Rac1-Dependent Spreading Are Impaired in Transitional Immature B Cells Due to Levels of Membrane Cholesterol
J. Immunol.,
October 1, 2007;
179(7):
4464 - 4472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Hoek, P. Antony, J. Lowe, N. Shinners, B. Sarmah, S. R. Wente, D. Wang, R. M. Gerstein, and W. N. Khan
Transitional B Cell Fate Is Associated with Developmental Stage-Specific Regulation of Diacylglycerol and Calcium Signaling upon B Cell Receptor Engagement
J. Immunol.,
October 15, 2006;
177(8):
5405 - 5413.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kovarova, C. A. Wassif, S. Odom, K. Liao, F. D. Porter, and J. Rivera
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
J. Exp. Med.,
May 15, 2006;
203(5):
1161 - 1171.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. Dunn, S. Youssef, M. J. Goldstein, T. Prod'homme, M. S. Weber, S. S. Zamvil, and L. Steinman
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
J. Exp. Med.,
February 21, 2006;
203(2):
401 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|